BUT, in 45 days there will be a new variant
Pfizer CEO Albert Bourla on Monday said that his company is aiming to have a vaccine that targets the omicron variant as well as other COVID-19 variants ready in March. “This vaccine will be ready in March,” Bourla said in an appearance on CNBC’s “Squawk Box.” “We [are] already starting manufacturing some of these quantities at risk,” he added.
h/t John Dutton
Views: